An expert discusses the treatment algorithm for patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), along with insurance coverage for the available treatment options.
Video content above is prompted by the following:
What is your treatment algorithm for patients with IPF and PPF?
Examining Health Equity Among Different Racial and Ethnic Subpopulations With Multiple Sclerosis
March 15th 2021Multiple sclerosis (MS) is a chronic disease that involves demyelination of plaque throughout the white and gray matter of the central nervous system. The early stages of MS are usually marked by a relapsing-remitting course of neurological deficits, which progress toward continuous, permanent dysfunction and disability. Of those with a diagnosis of MS, 74% are women.
Read More
Improving Ophthalmic Care Access and Treatment Among Aging Adults
August 20th 2020As the American population ages, chronic conditions are becoming an increasing challenge for payers. In addition to conditions such as cardiovascular disease and diabetes, eye disease is also prevalent among aging adults.
Read More